Why the study?
Does the ET-1 K198N (G/T) polymorphism interact with BMI to increase the risk of hypertension in Japanese populations?
Does the ET-1 K198N (G/T) polymorphism interact with BMI to increase the risk of hypertension in Japanese populations?
The ET-1 K198N T allele interacts with BMI to increase hypertension risk, suggesting T allele carriers may particularly benefit from weight reduction.
Answers are grounded in this paper and cite their sources.
Supports ET-1 K198N-BMI interaction in Japanese hypertension risk; hypothesis-generating, requires replication before clinical use.
Endothelin-1 (ET-1) is a powerful vasoconstrictor peptide produced by endothelial and smooth muscle cells. Many lines of biological evidence suggest that the ET-1 gene is a candidate gene for hypertension. Moreover, recent association studies suggested that a G/T polymorphism with an amino acid substitution (Lys/Asn) at codon 198 in exon 5 of the ET-1 gene interacts with body mass index (BMI) in association with blood pressure. They suggested that T carriers are more sensitive to weight gain than GG homozygotes in association with blood pressure. However, association studies are often irreproducible, and the first study often suggests a stronger genetic effect than is found by subsequent studies. We therefore assessed the interaction in 2 large Japanese populations. The present study showed a nonsignificant but similar trend to the results of previous reports. Moreover, in line with previous reports, this study revealed a significant interaction between the ET-1 K198N (G/T) polymorphism and BMI in association with hypertension in our populations (P=0.027). The interaction was significant, even after adjustment for gender and age (P=0.045) and for all confounding factors (P=0.044). T carriers were more sensitive to weight gain than GG homozygotes in association with hypertension. Considering the combined impact of obesity and hypertension on the development of cardiovascular and cerebrovascular disorders, T allele carriers might represent elective targets for therapy to lower their body weight.
No takes yet. Share an insight, caveat, or question.
Jin et al. (2003) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: